Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma
Authors
Keywords
PAAD, Multi-omics, Genomic mutation, Prognostic signature
Journal
PHARMACOLOGICAL RESEARCH
Volume 164, Issue -, Pages 105370
Publisher
Elsevier BV
Online
2020-12-12
DOI
10.1016/j.phrs.2020.105370
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
- (2019) Yang Cheng et al. EBioMedicine
- Prognostic value of differentially methylated gene profiles in bladder cancer
- (2019) Zeyu Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
- (2019) Natalia Anahi Juiz et al. Frontiers in Oncology
- Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma
- (2019) Mingjun Zheng et al. Aging-US
- Analysis of methylation‐driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma
- (2019) Yihua Pan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cytogenetics and Cytogenomics Evaluation in Cancer
- (2019) Ilda Patrícia Ribeiro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer
- (2019) Mengwei Wu et al. Frontiers in Oncology
- Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer
- (2018) Altaf Mohammed et al. CURRENT MEDICINAL CHEMISTRY
- MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK/cyclin D pathway
- (2018) Wenjie Deng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Activation of human gonadotropin-releasing hormone receptor promotes down regulation of ARHGAP18 and regulates the cell invasion of MDA-MB-231 cells
- (2018) Arturo Aguilar-Rojas et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Over-expression of ARHGAP18 suppressed cell proliferation, migration, invasion, and tumor growth in gastric cancer by restraining over-activation of MAPK signaling pathways
- (2018) Yan Li et al. OncoTargets and Therapy
- OUP accepted manuscript
- (2018) NUCLEIC ACIDS RESEARCH
- Pancreatic cancer survival analysis defines a signature that predicts outcome
- (2018) Pichai Raman et al. PLoS One
- A Kelch domain-containing KLHDC7B and a long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer cell proliferation via the interferon signaling pathway
- (2018) Gookjoo Jeong et al. Scientific Reports
- miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma
- (2018) Anteneh A. Tesfaye et al. AMERICAN JOURNAL OF PATHOLOGY
- Dysregulation of key microRNAs in pancreatic cancer development
- (2018) Behzad Baradaran et al. BIOMEDICINE & PHARMACOTHERAPY
- Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma
- (2018) Zhaoyang Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies
- (2017) Robert Matera et al. EXPERT OPINION ON EMERGING DRUGS
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells
- (2016) Wenjie Deng et al. BMC CANCER
- A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
- (2016) Shouhui Yang et al. CANCER RESEARCH
- Epidemiology of pancreatic cancer
- (2016) Milena Ilic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells
- (2015) Rossella Loria et al. Oncotarget
- Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
- (2013) Minoru Oshima et al. ANNALS OF SURGERY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Current Staging Systems for Pancreatic Cancer
- (2012) Betsy L. Appel et al. CANCER JOURNAL
- AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease Outcome
- (2012) Sojun Hoshimoto et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Rapid Characterization of Candidate Biomarkers for Pancreatic Cancer Using Cell Microarrays (CMAs)
- (2012) Min-Sik Kim et al. JOURNAL OF PROTEOME RESEARCH
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
- (2012) Geng Zhang et al. PLoS One
- High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer
- (2012) Paula Vainio et al. PLoS One
- Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer
- (2011) Kazimierz O. Wrzeszczynski et al. PLoS One
- AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy
- (2011) Eli Rosenbaum et al. PROSTATE
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started